Onconetix Inc (ONCO) | Stock Price, Analysis, News, Fundaments & Technical Information

stock

Onconetix Inc

NASDAQ | ONCO

4.26

USD

0.00 ( 0.00%)

AT CLOSE (AS OF Jun 16, 2025)

$2.5M

MARKET CAP

P/E Ratio

-161.5

EPS

$782

52 Week High

$4.1

52 Week Low

LIFE SCIENCES

Sector

ONCO Chart

Recent Chart

Price Action

Candles

ONCO Technicals

Tags:

ONCO Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field	Value (USD)
Gross Profit	$1.1M
Total Revenue	$2.5M
Cost Of Revenue	$1.5M
Costof Goods And Services Sold	$1.5M
Operating Income	-$10M
Selling General And Administrative	$11M
Research And Development	$154K
Operating Expenses	$13M
Investment Income Net	-
Net Interest Income	-$1.4M
Interest Income	$18
Interest Expense	$1.4M
Non Interest Income	-
Other Non Operating Income	-
Depreciation	-
Depreciation And Amortization	-
Income Before Tax	-$60M
Income Tax Expense	-
Interest And Debt Expense	-
Net Income From Continuing Operations	-$59M
Comprehensive Income Net Of Tax	-
Ebit	-
Ebitda	-
Net Income	-$59M

Revenue & Profitability

Earnings Performance

ONCO Financials

Highlights

Balance Sheet

Cash Flow

Income Statement

Yearly

Quarterly

yearly Balance Sheet (As of Dec 31, 2024)

Field	Value (USD)
Total Assets	$28M
Total Current Assets	$950K
Cash And Cash Equivalents At Carrying Value	$647K
Cash And Short Term Investments	$647K
Inventory	$64K
Current Net Receivables	$26K
Total Non Current Assets	$27M
Property Plant Equipment	-
Accumulated Depreciation Amortization Ppe	-
Intangible Assets	-
Intangible Assets Excluding Goodwill	-
Goodwill	$27M
Investments	-
Long Term Investments	-
Short Term Investments	-
Other Current Assets	-
Other Non Current Assets	-
Total Liabilities	$19M
Total Current Liabilities	$18M
Current Accounts Payable	$3.8M
Deferred Revenue	-
Current Debt	-
Short Term Debt	-
Total Non Current Liabilities	$281K
Capital Lease Obligations	$119K
Long Term Debt	-
Current Long Term Debt	$9.3M
Long Term Debt Noncurrent	-
Short Long Term Debt Total	-
Other Current Liabilities	$43K
Other Non Current Liabilities	-
Total Shareholder Equity	$9.6M
Treasury Stock	-
Retained Earnings	-$116M
Common Stock	-
Common Stock Shares Outstanding	$138K

yearly Cash Flow (As of Dec 31, 2024)

Field	Value (USD)
Operating Cashflow	-$10M
Payments For Operating Activities	-
Proceeds From Operating Activities	-
Change In Operating Liabilities	-
Change In Operating Assets	-
Depreciation Depletion And Amortization	$731K
Capital Expenditures	$28K
Change In Receivables	-
Change In Inventory	-$62K
Profit Loss	-
Cashflow From Investment	-
Cashflow From Financing	$6.7M
Proceeds From Repayments Of Short Term Debt	-
Payments For Repurchase Of Common Stock	-
Payments For Repurchase Of Equity	-
Payments For Repurchase Of Preferred Stock	-
Dividend Payout	-
Dividend Payout Common Stock	-
Dividend Payout Preferred Stock	-
Proceeds From Issuance Of Common Stock	-
Proceeds From Issuance Of Long Term Debt And Capital Securities Net	-
Proceeds From Issuance Of Preferred Stock	-
Proceeds From Repurchase Of Equity	-$718
Proceeds From Sale Of Treasury Stock	-
Change In Cash And Cash Equivalents	-
Change In Exchange Rate	-
Net Income	-$59M

yearly Income Statement (As of Dec 31, 2024)

Field	Value (USD)
Gross Profit	$1.1M
Total Revenue	$2.5M
Cost Of Revenue	$1.5M
Costof Goods And Services Sold	$1.5M
Operating Income	-$10M
Selling General And Administrative	$11M
Research And Development	$154K
Operating Expenses	$13M
Investment Income Net	-
Net Interest Income	-$1.4M
Interest Income	$18
Interest Expense	$1.4M
Non Interest Income	-
Other Non Operating Income	-
Depreciation	-
Depreciation And Amortization	-
Income Before Tax	-$60M
Income Tax Expense	-
Interest And Debt Expense	-
Net Income From Continuing Operations	-$59M
Comprehensive Income Net Of Tax	-
Ebit	-
Ebitda	-
Net Income	-$59M

ONCO News

ONCO Profile

Onconetix Inc Profile

Sector: LIFE SCIENCES

Industry: PHARMACEUTICAL PREPARATIONS

None